The fastest path from target to patentable peptide.
Stop waiting years for novel ingredients. Our AI self-driving foundry discovers, synthesizes, and wet-lab validates new peptides in weeks. We deliver exclusive, high-conviction candidates, saving your R&D team years of pre-clinical failure.
Or reach out to our team at contact@enloq.co
Generative AI designs novel peptide candidates against your target. Pre-filtered before any synthesis.
You don’t have an R&D problem. You have a search problem.
Every random-screening campaign is a lottery. Most hits fail at manufacturability. The rest get blocked on IP. Each cycle costs a budget line and a quarter of calendar. Your team isn’t slow — your search algorithm is. We replaced it with one that works.
- 10,000+ random sequences per campaign
- 2–3 years of wet-lab screening
- Hits collapse at stability, cost, or IP
- Manufacturability discovered late
- Opex-intensive, headcount-bound
- Targeted generation of novel geometries
- Closed-loop cycles compound across every target
- Filtered for stability, cost, and IP up front
- SPPS-native sequences only
- One design engine, not a lab army
The loop is already running.
These are the targets in flight.
Live programs across cosmetics and agriculture. Composition rights go exclusive the moment a target is locked.
From your brief
to our shortlist.
An autonomous AI science team. Agents form hypotheses, generate candidate peptides, design the experiments, run them in our wet lab, and feed the learnings back into the model. Every cycle starts sharper than the last.
Hypothesis
You bring the target — receptor, binding constraint, manufacturing envelope, IP whitespace. The loop translates it into a formal hypothesis to test.
In silico design
AI agents propose thousands of candidate peptides and pre-filter for binding, stability, manufacturability, and IP novelty.
Autonomous wet-lab validation
The shortlist is synthesized and run through wet-lab assays in our automated facility. Activity, binding, and stability are measured against your real target.
Learn & deliver
Validation data flows back into the model. Priors update; the next cycle starts sharper. You receive the IP-clean shortlist plus full dossier.
Before the call,
the obvious questions.
Don’t see yours? Ask us directly. We respond the same business day.
Your first peptide.
Skip the campaign.
Scope a target with us on a 30-minute call. We’ll tell you whether your problem is tractable in our closed loop, and what compressed discovery would look like.